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Leukemia accounts for a third of all cancers in children 
under the age of 15, mostly affecting industrialized 
countries, being the B-precursor acute lymphoblastic 
leukemia (pB-ALL) the most common type. The disease 
commonly strikes young children at the age of two to 
five years, and is treated with aggressive chemotherapy. 
In recent decades, more effective treatments have 
boosted survival rates and reduced mortality for 
childhood leukemia. However, according to SEER data 
from the National Cancer Institute, the incidence of 
lymphoblastic leukemia (ALL) in 0-14 year-old US 
children increased from 2.2 per 100,000 in 1975 to 4.0 
per 100,000 in 2005. This might be caused in part due 
to better cancer registries but there is little doubt that the 
real incidence of this “modern life-style” malignancy 
also rose. Hence, preventive strategies are clearly 
superior to any therapy improvement. Environmental 
exposures came into the focus of many epidemiologists 
who initiated a number of well-conducted studies 
aiming to elucidate the etiological role of infection, 
nuclear power-plants, background terrestrial irradiation 
and many other putative factors.   
Over the past century, infections have been regarded as 
the most likely cause of childhood leukemias [1]. But in 
general, epidemiological studies are descriptive and 
sometimes vary in their main conclusions. Similarly, 
when wild type mice were born and kept in the specific-
pathogen-free (SPF) environment until moved to 
common infectious environment they do not to develop 
pB-ALL [2]. These results suggest that delayed-
exposure to infection is not involved in the leukemia 
etiology. However, it is potentially possible that, in 
humans, infection-exposure favors pB-ALL in children 
harboring an intrinsic genetic susceptibility. Recently, 
germline mutations in PAX5 have been described as 
conferring an inherited risk for pB-ALL and pB-ALL 
occurs in affected children at reduced penetrance [3, 4]. 
To elucidate if pB-ALL is a result of infection exposure, 
Pax5+/- mice were exposed to common pathogens after 
being born in SPF condition. Pax5+/- mice developed 
clonal pB-ALL recapitulating the clinical, 
histopathological and molecular features of human pB-
ALL. These data represent the first proof that delayed 
exposure to infection can induce human-like pB-ALL in 
mice on the basis of inherited genetic predisposition, 
suggesting that a similar scenario may  occur  in  human  
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pB-ALL [2]. The demonstration that pB-ALL 
development can be established in mice by delayed 
exposure to infection implies that either abolishing 
infection or exposure to infection very early after birth 
will interfere with pB-ALL generation (Figure 1). In 
agreement with this, Pax5+/- mice kept under SPF 
environment during their lifespan did not spontaneously 
develop pB-ALL [2].   
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Figure  1.  Exposure to  infection  is  a  causal  factor  in  B‐
precursor acute lymphoblastic leukemia as a result of Pax5
inherited  susceptibility.  (A)  In  humans,  PAX5  c.547G>A
predisposes to pB‐ALL. Retention of PAX5 hypomorphic allele and
deletion of the wild type PAX5 allele  is observed  in about 30% of
PAX5  c.547G>A  carriers  and  results  in  pB‐ALL  development.  All
leukemia show deletions of chromosome 9p. However, knowledge
about preleukemic cell populations and environmental exposure is
not yet available in carrier families. (B) Without somatic secondary
genetic  events  –  e.g.  loss  of  the  wt  PAX5  allele  ‐  no  pB‐ALL
develops  (C) Pax5+/‐ mice acquire point mutations  in the second
allele of Pax5 when they are exposed to infection and this triggers
pB‐ALL development.  (D) Pax5+/‐ mice do not develop  leukemia
under non‐infection exposure conditions.  
Δ:  point  mutation;  +:  wild  type  Pax5  allele;  ‐:  deletion  of  Pax5
allele. 
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But the most crucial question is, how does infection 
exposure give rise to pB-ALL? In order to identify the 
mechanism of this specific pB-ALL susceptibility due 
to Pax5 heterozygosity under exposure to infections, we 
characterized both B-cell development in healthy and 
B-cells in leukemic Pax5+/- mice [2]. The data showed 
that monoallelic loss of Pax5 promotes leukemogenesis 
by creating an aberrant IL7-sensitive progenitor 
compartment. This pre-leukemic preB cell population is 
susceptible to malignant transformation through 
accumulation of secondary Jak3 mutations, which 
depicts a rescue mechanism of the IL7/IL7R/STAT5 
signaling. Transplantation experiments demonstrate that 
the activating Jak3 mutations per se are sufficient to 
drive leukemia. Thus targeting the deregulated 
JAK/STAT pathway can be a promising therapy for this 
disease. 
Patients with a genetic predisposition (Pax5 c.547G>A) 
loose the WT PAX5 allele related to a secondary 
structural aberration of chromosome 9p. In mice we 
face the same scenario but the sequence is reverse. The 
mice lack one Pax5 allele and acquire Pax5 point 
mutations on the remaining WT allele as a secondary 
event. The net result in both species is reduced 
transcriptional activity of Pax5 (Figure 1). The 
mechanisms responsible for the conversion of the 
preleukemic clone, carrying the inherited mutations of 
PAX5, into pB-ALL are not understood yet. However, 
recent results suggest that the B cell-specific enzyme 
AID is supposed to be the predominant driver of clonal 
evolution in human ETV6-RUNX1 pB-ALL [5, 6] and 
B-cell lymphoma [7]. The pB-ALL in our mouse model 
originated as a result of delayed infection exposure. It 
offers a unique possibility to confirm if the proposed 
AID-mechanisms are involved in the conversion of the 
preleukemic clone into a full-blown leukemia. 
Other major question that arise in light of these findings 
are if the timing and pattern of infectious exposure is 
indeed relevant for pB-ALL development, how the 
second hit impacts on the target cell, and what are the 
qualitative and/or quantitative figures that make 
Pax5+/- stem/progenitor target cells more vulnerable to 
malignancy. At the end, it will broaden our horizon and 
help us to change the way we approach childhood 
leukemia, from diagnosis and treatment to prevention 
first.  
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